Butabarbital decreases results of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of CYP3A4 inducers could decrease sufentanil degrees and efficacy, possibly precipitating withdrawal syndrome in people which have created Bodily dependence to sufentanil. Discontinuation of concomitantly applied CYP3A4 inducers may... https://jimj528vsm2.oneworldwiki.com/user